Tag Archives: Medicine

07Jan/22

NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting

AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the National Institute for Health and Care Excellence (NICE) has issued Medical Technologies Guidance (MTG) recommending KardiaMobile as an option for detecting atrial fibrillation (AF) for people with suspected paroxysmal AF, who present with symptoms such as palpitations and are referred for ambulatory ECG monitoring by a clinician. Continue reading

04Jan/22

For the first time in medical history, an autonomous drone helps save the life of a cardiac arrest patient

In the Swedish city of Trollhättan, a 71-year-old man was shoveling snow in his driveway when he suffered an out-of-hospital cardiac arrest (OHCA). Thanks to the combination of an immediate emergency call, the quick actions of Dr. Mustafa Ali and the swift delivery of an Automated External Defibrillator (AED), lifesaving measures through defibrillation could be initiated before the arrival of the ambulance, and his life was saved. Continue reading

04Dec/21

GreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidate

GreenLight Biosciences (ENVI) and IAVI, a nonprofit scientific research organization, today announced work on a messenger RNA vaccine candidate to tackle the COVID-19 Omicron variant. Continue reading

30Nov/21

78% of medical professionals concerned that cases are being discussed on social media

Research conducted by Wondr Medical has highlighted the growing concern among medical professionals in the United Kingdom about the widespread usage of Whatsapp and social media channels for medical conversations and interactions in a clinical setting. Continue reading

11Jul/21

Genetic factors linked to response to common antiviral medications

St. Jude Children’s Research Hospital scientists and collaborators in Sweden and Japan are reporting that the enzyme NUDT15 plays a role in how patients respond to antiviral therapy with the common drugs ganciclovir and acyclovir. The researchers showed that NUDT15 status can help predict how individuals will respond to treatment for cytomegalovirus, a serious infection common among people who receive bone marrow transplants. The paper was published today in Nature Communications. Continue reading

27May/21

As COVID-19 Vaccination Rates Rise, Grocery Shopping Behavior Dramatically Evolves

With the COVID-19 vaccination rate of adults receiving at least one dose now topping 60 percent in the U.S., and the Centers for Disease Control and Prevention (CDC) easing mask guidelines for those who have been vaccinated, recent grocery/CPG shopping data from shopper intelligence leader Catalina underscores the increasing enthusiasm for returning to a sense of normalcy sweeping the country after 15 months of varying degrees of restrictions. Continue reading

27May/21

As India Burns Amid a Lethal 2nd Wave, It’s Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released the 1st edition of its report titled “COVID-19 Vaccines – Global Market Trajectory & Analytics”. The report presents fresh perspectives on what to expect post commercialization of COVID-19 vaccines amid the rising spirit of vaccine nationalism, selfish international politics over vaccines, inadequate market access, stockpiling, and vaccine patents that still remain firmly in place. Continue reading

18May/21

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas® SARS-CoV-2 Test for use on the widely available, high-throughput cobas® 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. Continue reading

09Feb/21

Azerbaijan issues permit to conduct world’s first clinical trials of vaccine combination – Sputnik V and the AstraZeneca COVID-19 vaccine

Clinical trials of the combination of Sputnik V and AstraZeneca vaccines will begin in February 2021

The studies will assess the immunogenicity and safety of combined vaccine usage

The joint research is important in developing an approach to combat future mutations Continue reading

14Dec/20

Elsevier acquires Shadow Health, a leading provider of best-in-class healthcare simulations

Elsevier, a global leader in research publishing and information analytics, and part of RELX, has acquired Shadow Health, a Florida-based developer of virtual simulations in nursing and healthcare education.

Shadow Health’s Digital Clinical Experiences train and prepare nurses and healthcare practitioners for clinical settings. Its cutting-edge simulations, powered by Shadow Health’s Conversation Engine, enable learners to practice and apply their clinical reasoning skills through life-like interactions with a diverse range of virtual patients. Engaging in conversation-based learning, students gain confidence by practicing the skills they need to care for patients in a safe and standardized environment. Read more